Ardent Health Class Action Advances as March 9 Lead‑Plaintiff Deadline Nears
Plaintiff firms are recruiting lead candidates in a Tennessee suit alleging delayed loss recognition on receivables plus insufficient malpractice reserves.
Overview
- The case, Postiwala v. Ardent Health, Inc., No. 3:26-cv-00022, is pending in the U.S. District Court for the Middle District of Tennessee.
- Investors who purchased ARDT between July 18, 2024 and November 12, 2025 may seek appointment as lead plaintiff by March 9, 2026.
- Plaintiffs allege the company touted detailed collection reviews but actually used a 180‑day cliff that deferred reserving and inflated reported receivables.
- The complaint further contends malpractice insurance and reserves were inadequate in light of New Mexico claim developments and broader social inflation in litigation.
- On November 12, 2025, Ardent cut reported revenue by $43 million after revised collectability estimates and increased professional liability reserves by about $54 million, and the stock fell roughly 33% the next day.